Skip to main content

What's in The Cancer Genome Atlas?

Premium

With cancer researchers collecting more and more information on mutations, epigenetics, gene expression, and clinical features associated with different cancers, where does the information go? The data collected by large international groups like The Cancer Genome Atlas and the International Cancer Genome Consortium gets put into databases that are accessible to the public and searchable in various ways, says The Scientist's Carina Storrs. She has tips for researchers looking to use the information in these databases to help in their work.

Both groups' data portals allow for searches on mutation and expression data on specific genes, so that might be a good place to start, Storrs says. Or, there's also the possibility of searching through information on all known genes or pathways implicated in a certain tumor type. "Both ICGC and TCGA data are publicly available, but note that they have already been processed: sequences have been confirmed by various techniques, and patient-identifying information, such as the presence of germline SNPs, has been removed," Storrs says. Researchers can also search for gene drivers in various tumor types, frequency of certain mutations, or the functional impact of a given mutation.

Various universities and research centers, like Memorial Sloan-Kettering Cancer Center, also have their own cancer genomics databases, which can also be used as a starting point for research, Storr adds.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.